Ocular side effects of anticancer agents used in the treatment of gynecologic cancers Review
| Authors: | Crowley, F.; Broderick, S.; Francis, J. H.; O'Cearbhaill, R. E.; Canestraro, J. |
| Review Title: | Ocular side effects of anticancer agents used in the treatment of gynecologic cancers |
| Abstract: | The treatment landscape of gynecologic cancers has expanded in recent years to include targeted and immune-based therapies. These therapies often have ocular side effects not seen with conventional chemotherapies, some of which can cause significant visual impairment if not recognized in a timely fashion. Clinicians must know how to appropriately identify, mitigate, and treat these ocular adverse events. Management often involves working with an interdisciplinary team of eye specialists, and it is important to know when to refer patients for specialized care. Proactive identification of eye specialists, especially in rural and community settings where access to care can be limited, may be necessary. Here, we discuss the management of common ocular toxicities seen with novel anticancer agents used to treat gynecologic cancers. © 2024 |
| Keywords: | controlled study; review; side effect; antineoplastic agent; visual impairment; eye toxicity; health care access; targeted therapies; female genital tract cancer; treatment toxicity; human; multidisciplinary team; ocular side effects |
| Journal Title: | Gynecologic Oncology |
| Volume: | 188 |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-09-01 |
| Start Page: | 147 |
| End Page: | 157 |
| Language: | English |
| DOI: | 10.1016/j.ygyno.2024.06.003 |
| PROVIDER: | scopus |
| PUBMED: | 38964252 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledge in the PDF -- Corresponding authors are MSK authors: Roisin E. O'Cearbhaill and Julia Canestraro -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
256Francis -
271O'Cearbhaill
Related MSK Work